CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −117 | $546.84 | $64K | 333,826 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −575 | $547.79 | $315K | 333,251 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −948 | $548.95 | $520K | 332,303 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −586 | $550.02 | $322K | 331,717 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,134 | $551.03 | $625K | 330,583 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,560 | $551.85 | $861K | 329,023 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $553.14 | $133K | 328,783 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,260 | $553.97 | $698K | 327,523 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $555.09 | $89K | 327,363 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $556.06 | $245K | 326,923 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $557.12 | $178K | 326,603 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −520 | $558.72 | $291K | 326,083 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $559.70 | $157K | 325,803 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −315 | $560.67 | $177K | 325,488 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $561.84 | $202K | 325,128 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −464 | $562.78 | $261K | 324,664 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −221 | $563.56 | $125K | 324,443 |
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 195,410 | ||
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $534.75 | $86K | 333,783 |
Page 15 of 64 · 1,267 trades